Dhg Pharmaceutical Joint-Stock Co
VN:DHG
Dhg Pharmaceutical Joint-Stock Co
Inventory
Dhg Pharmaceutical Joint-Stock Co
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dhg Pharmaceutical Joint-Stock Co
VN:DHG
|
Inventory
₫1T
|
CAGR 3-Years
-6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
|
H
|
HaTay Pharmaceutical JSC
VN:DHT
|
Inventory
₫547.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
I
|
Imexpharm Corp
VN:IMP
|
Inventory
₫677.7B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
|
C
|
Cuu Long Pharmaceutical JSC
VN:DCL
|
Inventory
₫360.4B
|
CAGR 3-Years
5%
|
CAGR 5-Years
10%
|
CAGR 10-Years
6%
|
|
|
D
|
Domesco Medical Import Export Joint Stock Corp
VN:DMC
|
Inventory
₫528.2B
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
7%
|
|
|
T
|
Traphaco JSC
VN:TRA
|
Inventory
₫621.4B
|
CAGR 3-Years
8%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Dhg Pharmaceutical Joint-Stock Co
Glance View
DHG Pharmaceutical JSC engages in the production, sale, and trade of pharmaceutical products. The company is headquartered in Can Tho, Can Tho and currently employs 2,770 full-time employees. The company went IPO on 2006-12-21. The firm manufactures and markets pharmaceutical products, vitamins, supplements and cosmetics. Via its subsidiaries, the Company is also involved in packaging printing, herb cultivation, medicinal supplies trading, as well as domestic travel tour and medical clinic operation.
See Also
What is Dhg Pharmaceutical Joint-Stock Co's Inventory?
Inventory
1T
VND
Based on the financial report for Dec 31, 2025, Dhg Pharmaceutical Joint-Stock Co's Inventory amounts to 1T VND.
What is Dhg Pharmaceutical Joint-Stock Co's Inventory growth rate?
Inventory CAGR 10Y
5%
Over the last year, the Inventory growth was -8%. The average annual Inventory growth rates for Dhg Pharmaceutical Joint-Stock Co have been -6% over the past three years , 4% over the past five years , and 5% over the past ten years .
